Freezing prostate tumors shows promise in 354-Patient study
NCT ID NCT03503643
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 2 times
Summary
This study followed 354 men with low- to intermediate-risk prostate cancer who chose to freeze only the cancerous half of their prostate (hemi-gland cryoablation). Researchers tracked how well the treatment controlled the cancer and how it affected urinary function and quality of life. The goal was to see if this less invasive approach could offer effective disease control with fewer side effects.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- cryoablation (freezing treatment)
- What this could lead to
- If successful, this could show that hemi-gland cryoablation is a safe and effective way to control prostate cancer with fewer side effects than whole-gland treatments.
- What could go wrong
- This is an observational study, not a controlled trial, so results may not prove the treatment is better than others. It also only includes men who chose this procedure, which may limit how well the findings apply to everyone.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PROSTATE ADENOCARCINOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
University of California, Los Angeles
Los Angeles, California, 90095, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can surgery boost control of spread prostate cancer?
- Can a new tracer light up hidden prostate cancer?
- Could deep breaths before surgery ward off Post-Op confusion?
- A second look: MRI screening may spot hidden prostate cancers
- Can precision protons spare the bowel in prostate cancer?
- AI coaches doctors on cancer risk talks